PSNL
Personalis IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$1.00B
P/E Ratio
—
EPS
$-1.02
Beta
2.28
52W High
$12.53
52W Low
$3.84
50-Day MA
$7.48
200-Day MA
$7.95
Dividend Yield
—
Profit Margin
-148.10%
Forward P/E
—
PEG Ratio
—
About Personalis Inc
Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California.
Fundamentals
| Revenue (TTM) | $64.52M |
| Gross Profit (TTM) | $8.85M |
| EBITDA | $-92.69M |
| Operating Margin | -207.90% |
| Return on Equity | -41.40% |
| Return on Assets | -21.40% |
| Revenue/Share (TTM) | $0.69 |
| Book Value | $2.43 |
| Price-to-Book | 3.87 |
| Price-to-Sales (TTM) | 15.57 |
| EV/Revenue | 12.28 |
| EV/EBITDA | -0.03 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -24.90% |
| Shares Outstanding | $104.72M |
| Float | $64.49M |
| % Insiders | 27.05% |
| % Institutions | 68.15% |
Historical Volatility
HV 10-Day
94.88%
HV 20-Day
104.81%
HV 30-Day
93.98%
HV 60-Day
88.50%
HV Rank
65.5%
Volatility is currently expanding
Analyst Ratings
Consensus ($10.86 target)
1
Strong Buy5
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026